HIV co-receptor inhibitors as novel class of anti-HIV drugs

被引:31
作者
Schols, Dominique [1 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
CCR5; CXCR4; antagonist; HIV; chemokine receptor; gp120; envelope; HUMAN-IMMUNODEFICIENCY-VIRUS; CHEMOKINE RECEPTOR CXCR4; SMALL-MOLECULE INHIBITOR; HUMAN LYMPHOID-TISSUE; INFECTION IN-VITRO; TYPE-1; REPLICATION; CCR5; ANTAGONIST; HIGHLY POTENT; TROPIC HIV-1; SELECTIVE-INHIBITION;
D O I
10.1016/j.antiviral.2006.04.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Entry inhibitors constitute a new class of drugs to treat infection by human immunodeficiency virus type 1 (HIV-1). The first member of this class, enfuvirtide, previously known as T-20 and targeting gp41, has now been licensed for therapeutic use. Several other entry inhibitors are in various stages of pre-clinical or clinical development. In this review we focus on the chemokine receptor inhibitors targeting CCR5 and CXCR4 that are the main HIV co-receptors for viral entry. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:216 / 226
页数:11
相关论文
共 97 条
[11]   SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF PHENYLENEBIS(METHYLENE)-LINKED BIS-TETRAAZAMACROCYCLES THAT INHIBIT HIV REPLICATION - EFFECTS OF MACROCYCLIC RING SIZE AND SUBSTITUENTS ON THE AROMATIC LINKER [J].
BRIDGER, GJ ;
SKERLJ, RT ;
THORNTON, D ;
PADMANABHAN, S ;
MARTELLUCCI, SA ;
HENSON, GW ;
ABRAMS, MJ ;
YAMAMOTO, N ;
DEVREESE, K ;
PAUWELS, R ;
DECLERCQ, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) :366-378
[12]   Enfuvirtide [J].
Chen, RY ;
Kilby, JM ;
Saag, MS .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (12) :1837-1843
[13]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[14]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[15]   The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection [J].
Cocchi, F ;
DeVico, AL ;
GarzinoDemo, A ;
Cara, A ;
Gallo, RC ;
Lusso, P .
NATURE MEDICINE, 1996, 2 (11) :1244-1247
[16]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[17]  
Daelemans D, 2000, MOL PHARMACOL, V57, P116
[18]   HIGHLY POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY THE BICYCLAM DERIVATIVE JM3100 [J].
DE CLERCQ, E ;
YAMAMOTO, N ;
PAUWELS, R ;
BALZARINI, J ;
WITVROUW, M ;
DEVREESE, K ;
DEBYSER, Z ;
ROSENWIRTH, B ;
PEICHL, P ;
DATEMA, R ;
THORNTON, D ;
SKERLJ, R ;
GAUL, F ;
PADMANABHAN, S ;
BRIDGER, G ;
HENSON, G ;
ABRAMS, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :668-674
[19]   Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862
[20]   POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 AND HIV-2 REPLICATION BY A CLASS OF BICYCLAMS INTERACTING WITH A VIRAL UNCOATING EVENT [J].
DECLERCO, E ;
YAMAMOTO, N ;
PAUWELS, R ;
BABA, M ;
SCHOLS, D ;
NAKASHIMA, H ;
BALZARINI, J ;
DEBYSER, Z ;
MURRER, BA ;
SCHWARTZ, D ;
THORNTON, D ;
BRIDGER, G ;
FRICKER, S ;
HENSON, G ;
ABRAMS, M ;
PICKER, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5286-5290